Xarelto compensation settlements have been agreed in the sum of $775m (which is almost £600m) for some 25,000 cases being pursued in the U.S.
The Injury Lawyers have been fighting for justice for UK users of the medication, that’s also known as Rivaroxaban. Although the settlement is for the U.S. only, we’re pleased to see it has happened.
The settlement has been agreed without any admission of liability from the two companies behind the drug, Bayer AG and Johnson & Johnson. They reportedly maintain that the drug is fine for use and strongly deny the allegations that have been made against them. That includes previous allegations of a “cover-up” where important information was reportedly withheld from regulators.
Read More